(Q38012073)

27 August 2017

title

Antidiabetic properties of berberine: from cellular pharmacology to clinical effects (English)

1 reference

27 August 2017

1 reference

Arrigo F G Cicero

1

1 reference

27 August 2017

Elisa Tartagni

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

1 April 2012

1 reference

27 August 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Hospital Practice

1 reference

27 August 2017

volume

40

1 reference

27 August 2017

issue

2

1 reference

27 August 2017

page(s)

56-63

1 reference

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Standards of medical care in diabetes--2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Management of type 2 diabetes: new and future developments in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Targeting metabolic syndrome: candidate natural agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine: a potential phytochemical with multispectrum therapeutic activities

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

The involvement of P-glycoprotein in berberine absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Hepatobiliary excretion of berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Effects of herbal products and their constituents on human cytochrome P450(2E1) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Effects of berberine on glucose metabolism in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Facilitating effects of berberine on rat pancreatic islets through modulating hepatic nuclear factor 4 alpha expression and glucokinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine acutely inhibits insulin secretion from beta-cells through 3',5'-cyclic adenosine 5'-monophosphate signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine-induced activation of 5'-adenosine monophosphate-activated protein kinase and glucose transport in rat skeletal muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Traditional chinese medicine in treatment of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine reverses free-fatty-acid-induced insulin resistance in 3T3-L1 adipocytes through targeting IKKbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine improves glucose metabolism through induction of glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine stimulates glucose transport through a mechanism distinct from insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Effects and action mechanisms of berberine and Rhizoma coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states, evidences from in vivo and in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Efficacy of berberine in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Displacement of bilirubin from albumin by berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: Biphasic effect on CYP1A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FHP.2012.04.970

21 January 2018

Identifiers

DOI

10.3810/HP.2012.04.970

1 reference

27 August 2017

1 reference